The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Identification of the enzymatic mechanism of nitroglycerin bioactivation
Open accessAbstract
Nitroglycerin (glyceryl trinitrate, GTN), originally manufactured by Alfred Nobel, has been used to treat angina and heart failure for over 130 years. However, the molecular mechanism of GTN biotransformation has remained a mystery and it is not well understood why “tolerance” (i.e., loss of clinical efficacy) manifests over time. Here we purify a nitrate reductase that specifically catalyzes the formation of 1,2-glyceryl dinitrate and nitrite from GTN, leading to production of cGMP and relaxation of vascular smooth muscle both in vitro an d in vivo , and we identify it as mitochondrial aldehyde dehydrogenase (mtALDH). We also show that mtALDH is inhibited in blood vessels made tolerant by GTN. These results demonstrate that the biotransformation of GTN occurs predominantly in mitochondria through a novel reductase action of mtALDH and suggest that nitrite is an obligate intermediate in generation of NO bioactivity. The data also indicate that attenuated biotransformation of GTN by mtALDH underlies the induction of nitrate tolerance. More generally, our studies provide new insights into subcellular processing of NO metabolites and suggest new approaches to generating NO bioactivity and overcoming nitrate tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32738-2 · Cited by 1,633
Millar, T. M., Stevens, C. R., Benjamin, N., Eisenthal, R., Harrison, R., & Blake, D. R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00430-x · Cited by 491
Nitrite reductase activity is a novel function of mammalian mitochondria
Kozlov, A. V., Staniek, K., & Nohl, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00788-7 · Cited by 342
Research works printed but not linked: 46
- F Murad, C K Mittal, W P Arnold, S Katsuki, H Kimura Adv Cyclic Nucleotide Res 9, 145–158 (1978).
- L J Ignarro, H Lippton, J C Edwards, W H Baricos, A L Hyman, P J Kadowitz, C A Gruetter J Pharmacol Exp Ther 218, 739–749 (1981).
- 10.1016/S0735-1097(01)01507-8 · DOI
- 10.1016/S0002-8703(99)70163-8 · DOI · Paper page
- J F Brien, B E McLaughlin, S M Kobus, J H Kawamoto, K Nakatsu, G S Marks J Pharmacol Exp Ther 244, 322–327 (1988).
- 10.1097/00005344-199005000-00005 · DOI
- 10.1139/y89-221 · doi:10.1139/y89-221
- 10.1161/01.CIR.102.23.2810 · DOI
- 10.1016/S0021-9258(19)39092-1 · DOI
- 10.1016/0006-2952(89)90408-5 · DOI
- 10.1139/y90-236 · DOI
- 10.1016/0006-2952(93)90403-J · DOI
- 10.1016/0006-2952(93)90115-D · DOI
- 10.1016/S0006-2952(98)00216-0 · DOI
- R Nigam, D J Anderson, S F Lee, B M Bennett J Pharmacol Exp Ther 279, 1527–1534 (1996).
- T W Dean, D C Baun Am J Hosp Pharm 32, 1036–1038 (1975).
- 10.1016/S0021-9673(01)82416-X · doi:10.1016/s0021-9673(01)82416-x
- J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu, G S Marks J Pharmacol Exp Ther 237, 608–614 (1986).
- 10.1016/0003-2697(87)90235-1 · DOI
- 10.1016/S0021-9258(17)31857-4 · DOI
- 10.1016/S0021-9258(18)32405-0 · DOI
- 10.1007/978-1-4684-8577-6_8 · DOI
- 10.1006/bbrc.1995.1824 · DOI · Paper page
- 10.1016/S0891-5849(01)00754-7 · DOI
- 10.1016/S0021-9258(19)45785-2 · doi:10.1016/s0021-9258(19)45785-2
- P Needleman, B Jakschik, E M Johnson J Pharmacol Exp Ther 187, 324–331 (1973).
- 10.1161/01.RES.74.1.115 · DOI
- 10.1172/JCI117637 · DOI · Paper page
- 10.1126/science.7071604 · DOI · Paper page
- 10.1016/S0006-2952(00)00435-4 · DOI
- 10.1016/S0741-8329(96)00142-5 · DOI
- 10.1016/S0006-2952(98)00080-X · DOI · Paper page
- 10.1111/j.1530-0277.1985.tb05579.x · DOI
- 10.1016/0304-4165(80)90297-4 · DOI · Paper page
- E A Kowaluk, S J Chung, H L Fung Drug Metab Dispos 21, 967–969 (1993).
- 10.1016/S0022-2828(88)80130-5 · DOI
- 10.1021/bi002885x · DOI
- M Hay Practitioner 30, 422–433 (1883).
- 10.1021/bi00564a020 · DOI · Paper page
- 10.1006/bbrc.1998.9630 · DOI
- 10.1097/00005344-200005000-00007 · DOI
- F Brunner, K Schmidt, E B Nielsen, B Mayer J Pharmacol Exp Ther 277, 48–53 (1996).
- 10.1161/01.RES.84.2.210 · DOI · Paper page
- 10.1038/368850a0 · DOI · Paper page
- P Needleman, F E Hunter Mol Pharmacol 2, 134–143 (1966).
- 10.1016/S0009-2797(00)00211-8 · DOI · Paper page
Cited by
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Recent developments in nitric oxide donor drugs
Miller, M. R., & Megson, I. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707224 · Cited by 628
Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities
Chen, C.-H., Ferreira, J. C. B., Gross, E. R., & Mochly-Rosen, D. (2014) · Physiological Reviews · doi:10.1152/physrev.00017.2013 · Cited by 614
Castello, P. R., David, P. S., McClure, T., Crook, Z., & Poyton, R. O. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.011 · Cited by 495
Metadata
- Authors
- Chen, Z., Zhang, J., & Stamler, J. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-06-04
- Volume
- 99
- Issue
- 12
- Pages
- 8306-8311
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2086629541
- Cited by
- 541
- References
- 3
- FWCI
- 21.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of the enzymatic mechanism of nitroglycerin bioactivation. https://app.cochat.ai/papers/10.1073/pnas.122225199
- The paper
- Chen, Z., Zhang, J., & Stamler, J. S. (2002). Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.122225199
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.